Boehringer Ingelheim Biopharmaceuticals(China)Ltd.
勃林格殷格翰
Boehringer Ingelheim Biopharmaceuticals(China)Ltd.
Biotech/Healthcare
Boehringer Ingelheim China is a pharmaceutical R&D and manufacturing company focused on exploring disease areas where no effective treatments yet exist. Its main business is drug R&D and production, including human pharmaceuticals, animal health, and biopharmaceuticals.
Latest round: M&A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.